Optimize Vancomycin Dose in Surgical Ward Patients with Augmented Renal Clearance Determined by Chronic Kidney Disease Epidemiology Collaboration Equation

Li-Yu Chen,1 Chen-Yu Wang,1,2 Chi-Ying Lin,3 Ming-Jui Tsai,3 Wei-Hsun Shen,1 Pei-Jhih Li,1 Lin-Chu Liao,1 Chih-Fen Huang,4,5 Chien-Chih Wu4 1Department of Pharmacy, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 2National Center for Geriatrics and Welfare Research, National Healt...

Full description

Bibliographic Details
Published in:	Infection and Drug Resistance
Main Authors:	Chen LY, Wang CY, Lin CY, Tsai MJ, Shen WH, Li PJ, Liao LC, Huang CF, Wu CC
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-09-01
Subjects:	augmented renal clearance vancomycin surgery
Online Access:	https://www.dovepress.com/optimize-vancomycin-dose-in-surgical-ward-patients-with-augmented-rena-peer-reviewed-fulltext-article-IDR

Similar Items

The influence of augmented renal clearance on vancomycin blood concentrations in patients with traumatic brain injury: Case report
by: Miljković Milijana, et al.
Published: (2022-01-01)

Enhanced renal clearance and impact on vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke
by: Kathryn A. Morbitzer, et al.
Published: (2019-11-01)

Evaluation of vancomycin pharmacokinetics in patients with augmented renal clearances: A randomized clinical trial
by: Zahra Sahraei, et al.
Published: (2022-11-01)

Real-Life Vancomycin Therapeutic Drug Monitoring in Coagulase-Negative Staphylococcal Bacteremia in Neonatal and Pediatric Intensive Care Unit: Are We Underestimating Augmented Renal Clearance?
by: Claudia Sette, et al.
Published: (2023-10-01)

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
by: Sixuan Zhao, et al.
Published: (2021-10-01)

Age-associated augmented renal clearance and low BMI trigger suboptimal vancomycin trough concentrations in children with haematologic diseases: data of 1453 paediatric patients from 2017 to 2022
by: Fengjiao Wang, et al.
Published: (2023-10-01)

Altered Pharmacokinetics Parameters of Vancomycin in Patients with Hematological Malignancy with Febrile Neutropenia, a Bayesian Software Estimation
by: Abdullah M. Alzahrani, et al.
Published: (2023-05-01)

The Development and Validation of a Simple HPLC-UV Method for the Determination of Vancomycin Concentration in Human Plasma and Application in Critically Ill Patients
by: Asma Aboelezz, et al.
Published: (2025-02-01)

Clinical characteristics and early identification of augmented renal clearance in PICU patients with severe sepsis associated with MRSA infection
by: Haonan Wang, et al.
Published: (2024-11-01)

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate
by: Jeong Eun Shin, et al.
Published: (2015-11-01)

Association between Augmented Renal Clearance and Inadequate Vancomycin Pharmacokinetic/Pharmacodynamic Targets in Chinese Adult Patients: A Prospective Observational Study
by: Jinjin Zhao, et al.
Published: (2022-06-01)

Application of machine learning combined with population pharmacokinetics to improve individual prediction of vancomycin clearance in simulated adult patients
by: Guodong Li, et al.
Published: (2024-03-01)

The effect of body mass index and creatinine clearance on serum trough concentration of vancomycin in adult patients
by: Yuyan Pan, et al.
Published: (2020-05-01)

Augmented Renal Clearance and How to Augment Antibiotic Dosing
by: Iris H. Chen, et al.
Published: (2020-07-01)

Vancomycin population pharmacokinetics in patients with burns
by: Yan Shi, et al.
Published: (2026-06-01)

Enhanced renal clearance impacts levetiracetam concentrations in patients with traumatic brain injury with and without augmented renal clearance
by: Aaron M. Cook, et al.
Published: (2024-01-01)

Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance
by: Bin Du, et al.
Published: (2021-03-01)

Individualized antibiotic dosage regimens for patients with augmented renal clearance
by: A-Xi Shi, et al.
Published: (2023-07-01)

Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
by: Thibaud Besnard, et al.
Published: (2019-01-01)

Onset timing and duration of augmented renal clearance in a mixed intensive care unit
by: Ryusei Mikami, et al.
Published: (2023-03-01)

Incidence and predictors of vancomycin nephrotoxicity and mortality in patients with chronic liver disease: a two-center retrospective cohort study
by: Reem F. Bamogaddam, et al.
Published: (2025-03-01)

Factors influencing vancomycin trough concentration in burn patients: a single center retrospective study
by: Yan Shi, et al.
Published: (2024-12-01)

Evaluating Anti-factor Xa Levels in Patients with Augmented Renal Clearance Receiving Enoxaparin Prophylaxis: An Exploratory Pilot Study
by: Zahra Sahraei, et al.
Published: (2025-01-01)

Epidemiology of Vancomycin-Resistant Enterococci in Various Medical Wards
by: A. V. Liubimova, et al.
Published: (2016-08-01)

Optimization of meropenem dosing regimens in critically ill patients with augmented renal clearance
by: Jinfeng Luo, et al.
Published: (2025-05-01)

Development and validation of the prediction score for augmented renal clearance in critically Ill Japanese adults
by: Ryusei Mikami, et al.
Published: (2024-11-01)

Gait Training with Real-Time Augmented Toe-Ground Clearance Information Decreases Tripping Risk in Older Adults and a Person with Chronic Stroke
by: Rezaul K Begg, et al.
Published: (2014-05-01)

Development of a decision flowchart to identify the patients need high-dose vancomycin in early phase of treatment
by: Ryo Yamaguchi, et al.
Published: (2022-01-01)

Prevalence and Risk Factors of Augmented Renal Clearance: A Systematic Review and Meta-Analysis
by: Fatma Hefny, et al.
Published: (2022-02-01)

Predicting vancomycin trough serum concentration in augmented renal clearance patients through an artificial neural network model
by: Puxiu Wang, et al.
Published: (2023-12-01)

Vancomycin Exposure Dynamics and Clinical Outcomes in Critically Ill Patients: A Retrospective Cohort Study
by: Mohamad Amer Nashtar, et al.
Published: (2026-06-01)

Colistin Use in Patients with Extreme Renal Function: From Dialysis to Augmented Clearance
by: Aleksandra Aitullina, et al.
Published: (2019-01-01)

Augmented renal clearance in critically ill patients with cancer (ARCCAN Study): A prospective observational study evaluating prevalence and risk factors
by: Lama H. Nazer, et al.
Published: (2021-04-01)

Epidemiology of S. aureus Non-Susceptible to Vancomycin in Western Asia
by: Zean Zefenkey, et al.
Published: (2024-12-01)

Factors Affecting Vancomycin Trough Concentration; a Population Pharmacokinetic Model in Non-Critical Care Saudi Patients
by: Alqurain AA, et al.
Published: (2024-12-01)

Factors affecting vancomycin-resistant Enterococcus faecium colonization of in-hospital patients in different wards
by: Yun-Cheng Wang, et al.
Published: (2024-01-01)

Machine learning for the prediction of augmented renal clearance (ARC) in patients with sepsis in critical care units
by: Tong Wu, et al.
Published: (2025-07-01)

The in vitro elution characteristics of vancomycin from the ligament augmentation and reconstruction system
by: Yong Luo, et al.
Published: (2024-10-01)

Characterizing Day 1 Area Under the Curve Following Vancomycin Loading Dose Administration in Adult Hospitalized Patients Using Non-Trapezoidal Linear Pharmacokinetic Equations: A Retrospective Observational Study
by: Abdulwhab Shremo Msdi, et al.
Published: (2024-06-01)

The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections
by: Olaniyi Ayobami, et al.
Published: (2020-01-01)